A comparison of the fixed combination of latanoprost and timolol with its individual components

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 240, Issue 11, 2002, Pages 893-899

  Pfeiffer, Norbert ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; LATANOPROST; TIMOLOL;

ADULT; AGED; ARTICLE; BILIARY TRACT DISEASE; BLEPHARITIS; CARDIOVASCULAR DISEASE; CATARACT; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; CONJUNCTIVAL HYPEREMIA; CONJUNCTIVITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA DISEASE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; EYE IRRITATION; FEMALE; FLU LIKE SYNDROME; GLAUCOMA; HEADACHE; HUMAN; HYPERTENSION; HYPERTRICHOSIS; INCIDENCE; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; IRIS DISEASE; IRITIS; LIVER DISEASE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MONOTHERAPY; MULTICENTER STUDY; OPEN STUDY; OPTIC NERVE ATROPHY; PRESSURE MEASUREMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REFRACTION ERROR; RESPIRATORY TRACT DISEASE; SLEEP DISORDER; STATISTICAL ANALYSIS; VERTIGO; VISUAL IMPAIRMENT;

EID: 0036947024     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-002-0553-0     Document Type: Article

References (16)

1. Alm A, Stjernschantz J, the Scandinavian Latanoprost Study Group (1995) Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Ophthalmology 102:1743-1752
2. Alm A, Widengård I, Kjellgren D, et al (1995) Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol. Br J Ophthalmol 79:12-16
3. Bucci MG and the Italian Latanoprost Study Group (1999) Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. J Glaucoma 8:24-30
4. Camras CB, the United States Latanoprost Study Group (1996) Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma. A six-month, masked, multicenter trial in the United States. Ophthalmology 103:138-147
5. Cartwright MJ, Anderson DR (1988) Correlation of asymmetric damage with asymmetric intraocular pressure in normal-tension glaucoma (low-tension glaucoma). Arch Ophthalmol 106:898-900
6. Collaborative Normal-Tension Glaucoma Study Group (1998) Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol 126:487-497
7. Crichton A, Drance SM, Douglas GR, Schulzer M (1989) Unequal intraocular pressure and its relation to asymmetric visual field defects in low-tension glaucoma. Ophthalmology 96:1312-1314
8. Diestelhorst M, Almegård B (1998) Comparison of two fixed combinations of latanoprost and timolol in open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol 236:577-581
9. Gurwitz JH, Glynn RJ, Monane M, Mack RJ, Lass JH (1993) Treatment of glaucoma: adherence by the elderly. Am J Public Health 83:711-716
10. Johnstone MA (1997) Hypertrichosis and increased pigmentation of eyelashes and adjacent hair in the region of the ipsilateral eyelids of patients treated with unilateral topical latanoprost. Am J Ophthalmol 124:544-547
11. Lindén C, Nuija E, Alm A (1997) Effects of IOP restoration and blood-aqueous barrier after long term treatment with latanoprost in open angle glaucoma and ocular hypertension. Br J Ophthalmol 81:370-372
12. Mao LK, Williams CS, Shields MB (1991) Correlation between intraocular pressure control and progressive glaucomatous damage in primary open-angle glaucoma. Am J Ophthalmol 111:51-55
13. Mishima HK, Masuda K, Kitazawa Y, Azuma L, Araie M (1996) A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. A 12-week study. Arch Ophthalmol 114:929-939
14. Rácz P, Ruzsonyi MR, Nagy ZT, Bito LZ (1993) Maintained intraocular pressure reduction with once-a-day application of a new prostaglandin F2 alpha analogue (PhXA41). An in-hospital, placebo-controlled study. Arch Ophthalmol 111:657-661
15. 2α analogue, and timolol in patients with elevated intraocular pressure. Br J Ophthalmol 78:899-902
16. Watson P, Stjernschantz J, the Latanoprost Study Group (1996) A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. Ophthalmology 103:126-137